Published in Int J Radiat Oncol Biol Phys on January 01, 1992
Radiation techniques in neuro-oncology. Neurotherapeutics (2009) 0.82
A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys (2000) 7.50
More on managing metastatic choroidal tumors. Oncology (Williston Park) (1989) 5.12
Carcinoma of the cervix: predictive value of clinical and magnetic resonance (MR) imaging assessment of prognostic factors. Int J Radiat Oncol Biol Phys (1993) 2.13
Oxygen in human tumors: correlations between methods of measurement and response to therapy. Summary of a workshop held November 19-20, 1992, at the National Cancer Institute, Bethesda, Maryland. Radiat Res (1993) 1.99
Radiation pneumonitis following combined modality therapy for lung cancer: analysis of prognostic factors. J Clin Oncol (1995) 1.96
Influence of fraction size, total dose, and overall time on local control of T1-T2 glottic carcinoma. Int J Radiat Oncol Biol Phys (1997) 1.93
A distinctive glioneuronal tumor of the adult cerebrum with neuropil-like (including "rosetted") islands: report of 4 cases. Am J Surg Pathol (1999) 1.85
Carcinoma of the extrahepatic bile ducts. The University of California at San Francisco experience. Ann Surg (1994) 1.72
Injury to the lung from cancer therapy: clinical syndromes, measurable endpoints, and potential scoring systems. Int J Radiat Oncol Biol Phys (1995) 1.71
Survival benefit of hyperthermia in a prospective randomized trial of brachytherapy boost +/- hyperthermia for glioblastoma multiforme. Int J Radiat Oncol Biol Phys (1998) 1.71
Experience in charged particle irradiation of tumors of the skull base: 1977-1992. Int J Radiat Oncol Biol Phys (1994) 1.70
Uveal melanoma. Growth rate and prognosis. Arch Ophthalmol (1997) 1.67
Helium ions versus iodine 125 brachytherapy in the management of uveal melanoma. A prospective, randomized, dynamically balanced trial. Ophthalmology (1993) 1.67
Gamma knife radiosurgery for malignant melanoma brain metastases. Cancer J Sci Am (1998) 1.63
Can we identify who will adhere to long-term physical activity? Signal detection methodology as a potential aid to clinical decision making. Health Psychol (1997) 1.63
A randomized phase III protocol for the evaluation of misonidazole combined with radiation in the treatment of patients with brain metastases (RTOG-7916). Int J Radiat Oncol Biol Phys (1991) 1.63
Transport of membrane-bound macromolecules by M cells in follicle-associated epithelium of rabbit Peyer's patch. Cell Tissue Res (1987) 1.59
Positive and negative regulation of epicardial-mesenchymal transformation during avian heart development. Dev Biol (2001) 1.58
A phase 3 randomized study of radiotherapy plus procarbazine, CCNU, and vincristine (PCV) with or without BUdR for the treatment of anaplastic astrocytoma: a preliminary report of RTOG 9404. Int J Radiat Oncol Biol Phys (1999) 1.58
RTOG Late Effects Working Group. Overview. Late Effects of Normal Tissues (LENT) scoring system. Int J Radiat Oncol Biol Phys (1995) 1.57
High-dose-rate versus low-dose-rate intracavitary brachytherapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys (1990) 1.56
Dose conformity of gamma knife radiosurgery and risk factors for complications. Int J Radiat Oncol Biol Phys (2001) 1.52
Radiosurgery for brain metastases: is whole brain radiotherapy necessary? Int J Radiat Oncol Biol Phys (1999) 1.50
Gamma knife radiosurgery in children. Pediatr Neurosurg (1996) 1.43
Failure of preenucleation radiation to decrease uveal melanoma mortality. Am J Ophthalmol (1988) 1.42
Vision following helium ion radiotherapy of uveal melanoma: a Northern California Oncology Group study. Int J Radiat Oncol Biol Phys (1988) 1.39
Patterns of recurrence of glioblastoma multiforme after external irradiation followed by implant boost. Int J Radiat Oncol Biol Phys (1994) 1.34
A Carboniferous insect gall: insight into early ecologic history of the Holometabola. Proc Natl Acad Sci U S A (1996) 1.34
The neurotoxicity of misonidazole: pooling of data from five centres. Br J Radiol (1978) 1.31
Treatment planning for heavy ion radiotherapy. Int J Radiat Oncol Biol Phys (1979) 1.30
Rhabdomyosarcoma of head and neck in children. Combination treatment by surgery, irradiation, and chemotherapy. Cancer (1973) 1.29
Economic evaluation of interventions to reduce road traffic injuries--a review of the literature with applications to low and middle-income countries. Asia Pac J Public Health (2004) 1.26
Desmoid tumors--treatment and prognosis. Radiology (1977) 1.26
Soft tissue sarcomas of the extremities: survival and patterns of failure with conservative surgery and postoperative irradiation compared to surgery alone. Cancer (1982) 1.24
Large effect of age on the survival of patients with glioblastoma treated with radiotherapy and brachytherapy boost. Neurosurgery (1995) 1.21
An ultrastructural study of the development of radiation injury in the lung. Radiology (1966) 1.21
The accuracy of lymphangiography in carcinoma of the uterine cervix. Am J Roentgenol Radium Ther Nucl Med (1971) 1.19
A therapeutic benefit from combining normobaric carbogen or oxygen with nicotinamide in fractionated X-ray treatments. Radiother Oncol (1991) 1.18
Desmoid tumors: local control and patterns of relapse following radiation therapy. Int J Radiat Oncol Biol Phys (1983) 1.17
Kidney cell proliferation after unilateral nephrectomy as related to age. Cancer Res (1967) 1.16
Single-agent chemotherapy of a solid murine tumor assayed by growth delay and cell survival. Cancer Res (1980) 1.16
Modification of radiation injury to normal tissues by chemotherapeutic agents. Cancer (1975) 1.15
Malignant tumors of the testis: analysis of treatment results and sites and causes of failure. Cancer (1977) 1.14
Radiosurgery for brain metastases: relationship of dose and pattern of enhancement to local control. Int J Radiat Oncol Biol Phys (1997) 1.14
Radiation retinopathy. Int J Radiat Oncol Biol Phys (1979) 1.12
The neurotoxicity of misonidazole: potential modifying role of phenytoin sodium and dexamethasone. Br J Radiol (1980) 1.12
Five year results of LINAC radiosurgery for arteriovenous malformations: outcome for large AVMS. Int J Radiat Oncol Biol Phys (1999) 1.10
Liposomes and hyperthermia in mice: increased tumor uptake and therapeutic efficacy of doxorubicin in sterically stabilized liposomes. Cancer Res (1994) 1.08
Radiation response of artificial pulmonary metastases of the EMT6 tumor. Int J Radiat Oncol Biol Phys (1976) 1.08
High intensity 125-iodine (125I) plaque treatment of uveal melanoma. Int J Radiat Oncol Biol Phys (1993) 1.07
Defining treatment margins for six field conformal irradiation of localized prostate cancer. Int J Radiat Oncol Biol Phys (1994) 1.07
Stereotaxic irradiation of brain tumors. Cancer (1990) 1.07
Initial United States clinical and pharmacologic evaluation of misonidazole (Ro-07-0582), an hypoxic cell radiosensitizer. Int J Radiat Oncol Biol Phys (1979) 1.06
Five-year follow-up of helium ion therapy for uveal melanoma. Arch Ophthalmol (1990) 1.06
Carcinoma of the major and minor salivary glands: analysis of treatment results and sites and causes of failures. Cancer (1977) 1.05
Prognostic factors in adult soft-tissue sarcomas of the head and neck. Int J Radiat Oncol Biol Phys (1997) 1.05
Dose volume histogram analysis of liver radiation tolerance. Int J Radiat Oncol Biol Phys (1986) 1.05
Differential protection against cytotoxic chemotherapeutic effects on bone marrow CFUs by Wr-2721. Cancer Clin Trials (1981) 1.04
Quantification of combined radiation therapy and chemotherapy effects on critical normal tissues. Cancer (1976) 1.04
Time-dose relationships in the mouse esophagus. Radiology (1974) 1.03
Identification of an optimal subgroup for treatment evaluation of patients with brain metastases using RTOG study 7916. Int J Radiat Oncol Biol Phys (1989) 1.03
Electrophoresis of 35S-labeled proteoglycans on polyacrylamide-agarose composite gels and their visualization by fluorography. Anal Biochem (1986) 1.03
Radiation pneumonitis: a new approach to the derivation of time-dose factors. Cancer (1973) 1.02
Radiotherapy for high grade clinically localized adenocarcinoma of the prostate. J Urol (1996) 1.02
Neon ion radiotherapy: results of the phase I/II clinical trial. Int J Radiat Oncol Biol Phys (1991) 1.02
Anterior segment complications after helium ion radiation therapy for uveal melanoma. Radiation cataract. Arch Ophthalmol (1994) 1.01
Radiation tolerance of the spinal cord. Cancer (1975) 1.01
Integration of multimodality imaging data for radiotherapy treatment planning. Int J Radiat Oncol Biol Phys (1991) 1.00
Phase III trial of accelerated hyperfractionation with or without difluromethylornithine (DFMO) versus standard fractionated radiotherapy with or without DFMO for newly diagnosed patients with glioblastoma multiforme. Int J Radiat Oncol Biol Phys (2001) 1.00
Elevated IGA in carcinoma of the nasopharynx. Cancer (1975) 1.00
Should asymptomatic patients with inoperable bronchogenic carcinoma receive immediate radiotherapy? Yes. Am Rev Respir Dis (1978) 0.99
High activity iodine-125 interstitial implant for gliomas. Int J Radiat Oncol Biol Phys (1992) 0.99
EORTC Late Effects Working Group. Overview of late effects normal tissues (LENT) scoring system. Radiother Oncol (1995) 0.99
The potential for adjuvant radiotherapy in choroidal melanoma. Arch Ophthalmol (1982) 0.99
Effect of various doses of radiation for uveal melanoma on regression, visual acuity, complications, and survival. Am J Ophthalmol (1989) 0.99
Treatment of cancer with heavy charged particles. Int J Radiat Oncol Biol Phys (1982) 0.98
Helium ion therapy for choroidal melanoma. Arch Ophthalmol (1982) 0.98
External irradiation followed by an interstitial high activity iodine-125 implant "boost" in the initial treatment of malignant gliomas: NCOG study 6G-82-2. Int J Radiat Oncol Biol Phys (1991) 0.97
Highly anaplastic astrocytoma: a review of 357 patients treated between 1977 and 1989. Int J Radiat Oncol Biol Phys (1992) 0.97
Results and prognostic factors in the retreatment of locally recurrent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys (1998) 0.97
Failure of choroidal melanoma to respond to helium ion therapy. Arch Ophthalmol (1983) 0.97
Uveal melanoma radiation. 125I brachytherapy versus helium ion irradiation. Ophthalmology (1989) 0.96
Practical induction heating coil designs for clinical hyperthermia with ferromagnetic implants. IEEE Trans Biomed Eng (1994) 0.96
Improved freedom from PSA failure with whole pelvic irradiation for high-risk prostate cancer. Int J Radiat Oncol Biol Phys (1998) 0.95
Brachytherapy of recurrent malignant brain tumors with removable high-activity iodine-125 sources. J Neurosurg (1984) 0.95
Survival comparison of radiosurgery-eligible and -ineligible malignant glioma patients treated with hyperfractionated radiation therapy and carmustine: a report of Radiation Therapy Oncology Group 83-02. J Clin Oncol (1993) 0.94